Newsfeeds - Spark Newswire

1 minute read

Altamira Therapeutics Reports Approval Of Bentrio Nasal Spray In Malaysia

Today, 5:58 AM

Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics announced today that

CYTO

5 minute read

63 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:58 AM

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.

AGMH

3 minute read

44 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 5:58 AM

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.

AGMH

2 minute read

20 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 5:58 AM

Gainers BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) rose 33.6% to $3.10 in pre-market trading. BiondVax reported successful closing of $9.8 million follow-on underwritten offering of ADSs including exercise of the over-allotment.

ARDS

4 minute read

45 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:58 AM

Gainers Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter.

ADTH

2 minute read

26 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 5:58 AM

Gainers Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter.

AUVI

2 minute read

21 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

Today, 5:58 AM

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) rose 95.5% to $2.19 in pre-market trading after surging 43% on Tuesday.

AUVI

5 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:58 AM

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.

AEHR